Intelligence · Clinical Pipeline
Aligos Therapeutics Pipeline
All ClinicalTrials.gov programs at Aligos Therapeutics — phase, modality, and trial IDs.
- Programs
- 3
Quick answer
Aligos Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
ALG-000184
Aligos Therapeutics
Chronic Hepatitis B Infection
1 trial -
ALG-000184, ALG-000184 Placebo, Tenofovir Disoproxil Placebo, Tenofovirdisoproxil Amarox 245 mg Filmtabletten
Aligos Therapeutics
Chronic Hepatitis B Virus Infection
1 trial -
ALG-055009
Aligos Therapeutics
NASH
1 trial
Frequently asked questions
How many pipeline programs does Aligos Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs